APA (7th ed.) Citation

YP, C., LL, S., YY, L., YM, Z., SZ, Z., HD, H., . . . LY, Z. (2025). Isoliquiritigenin alleviates radiation-induced intestinal injury in lung cancer by inhibiting TNF-α/caspase3 signaling pathway. Naunyn-Schmiedeberg's archives of pharmacology, 398(9), 12353. https://doi.org/10.1007/s00210-025-04007-z

Chicago Style (17th ed.) Citation

YP, Chen, et al. "Isoliquiritigenin Alleviates Radiation-induced Intestinal Injury in Lung Cancer by Inhibiting TNF-α/caspase3 Signaling Pathway." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 9 (2025): 12353. https://doi.org/10.1007/s00210-025-04007-z.

MLA (9th ed.) Citation

YP, Chen, et al. "Isoliquiritigenin Alleviates Radiation-induced Intestinal Injury in Lung Cancer by Inhibiting TNF-α/caspase3 Signaling Pathway." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 9, 2025, p. 12353, https://doi.org/10.1007/s00210-025-04007-z.